Cipla gets 7 observations from USFDA after inspection at Pithampur facility - What investors need to know

Cipla shares fell over 1 per cent on Tuesday after the USFDA issued seven observations following an inspection at its Pithampur facility. The company said it is committed to addressing the observations comprehensively within the stipulated time. This news follows a recent 39 per cent drop in quarterly net profit.